The Transferee’s Mandate: A Comprehensive Analysis of the Kansas R&D Tax Credit Transferability Provisions (K.S.A. 79-32,182b)
The Transferee, or Recipient of Credit, is the party that legally acquires the Kansas Research and Development (R&D) tax credit from the original entity that generated it. This Transferee claims the acquired asset as a credit against their own Kansas income tax liability, adhering to strict statutory requirements regarding utilization and carryforward.
Effective for tax years commencing after December 31, 2022, the Kansas R&D tax credit was legislatively converted into a marketable asset through transferability provisions established in K.S.A. 79-32,182b.1 This transformation provides a mechanism for R&D-intensive businesses that lack sufficient tax liability to monetize their generated credits immediately for cash. The Transferee serves as the critical financial counterparty, injecting capital into the R&D ecosystem in exchange for a future stream of tax offsets. The utility of this asset for the Transferee is strictly defined by two major statutory constraints: the credit is non-refundable, and its annual utilization is capped at 25% of the total credit base plus applicable carryforwards.3
II. Statutory Interpretation of Transferee Status (K.S.A. 79-32,182b)
A. Legal Basis and Legislative Intent for Transferability
The authority for the transfer of the R&D credit is established by K.S.A. 79-32,182b(d), which applies to all taxable years beginning on or after January 1, 2023.1 This legislation allows the credit to be transferred by a taxpayer who earned it, provided that the generating entity, referred to as the Transferor, does not have a current Kansas tax liability.1 This specific requirement for the Transferor ensures that the transferred credit genuinely represents an unused asset, preventing the original generator from simultaneously benefiting from a liability reduction and a cash sale of the same credit. For the Transferee, performing due diligence to verify the Transferor’s zero current liability status is a necessary step in validating the legality of the transaction.
The legislative decision to introduce transferability was strategically paired with an enhancement of the credit itself. For taxable years commencing after December 31, 2022, the credit rate was increased from 6.5% to 10% of the qualified excess expenditures.2 This increase amplified the face value of the underlying asset, making the transferable credit significantly more attractive and financially viable for potential Transferees, thus driving market demand and ensuring the success of the monetization program. Furthermore, the removal of the limitation that previously restricted the credit solely to C corporations, making it available to individuals and various flow-through entities beginning in 2023, broadened the pool of eligible Transferors and thereby increased the supply of available credits on the market.2
B. Defining the Recipient and Eligible Tax Liabilities
The definition of the Transferee is exceptionally broad under the statute, specifying that the R&D credit may be transferred to “any person”.1 This comprehensive language permits entities across the tax spectrum—including C corporations (filing Form K-120), pass-through entities, and individual taxpayers (filing Form K-40 or K-41)—to acquire and utilize the credit, provided they possess a current or anticipated Kansas income tax liability.2
The purpose of the acquisition, from the Transferee’s perspective, is to claim the credit against the “transferee’s Kansas income tax liability”.2 This includes any tax imposed by the Kansas income tax act. It is important to distinguish the R&D credit transfer mechanism from previous, more restrictive forms of credit transfer, such as those governing facility-based credits (e.g., K.S.A. 79-32,233). Those older provisions often restricted transfers to related taxpayers upon the acquisition or lease of a qualified business facility.5 In contrast, K.S.A. 79-32,182b establishes an explicit open-market mechanism, enabling the Transferee to be any unrelated entity capable of using the tax offset.1
C. Absolute Constraints on the Credit Transfer
The acquisition and subsequent utilization of the credit by the Transferee are subject to three absolute, non-negotiable statutory constraints designed to ensure administrative control and manage fiscal risk:
- Full Credit Requirement: The law mandates that “Only the full credit may be transferred”.2 This prohibits any fractionalized sale, meaning the Transferee must purchase the entire generated credit base, including its multi-year carryforward potential, in one transaction. This regulatory rigidity is instrumental in stabilizing the emerging market for these credits and simplifying oversight for the Kansas Department of Revenue (KDOR), as it confirms that the entire tax asset remains consolidated under one owner.
- Single Transfer Limitation: The statute limits the transaction by stating the credit “may only be transferred one time”.2 Once a Transferor has sold the credit to a Transferee, that credit cannot be resold or transferred again by the Transferee. This rule definitively fixes the identity of the entity responsible for the long-term utilization and compliance tracking of the credit, significantly reducing the administrative complexity that would arise from tracking multiple secondary market sales.
- Non-Refundability for Transferee: A crucial financial constraint is that “No person shall be entitled to a refund for the transferred tax credit”.2 If the portion of the credit allowable for deduction in any given year exceeds the Transferee’s actual tax liability, that excess amount is not refunded as cash but must be carried forward indefinitely for use in future taxable years.3 This non-refundable nature, combined with the annual utilization cap, defines the core financial risk assumed by the Transferee: they are purchasing a deferred asset whose value realization is contingent upon maintaining sufficient future Kansas tax liability. The purchase price must consequently reflect a substantial discount from the credit’s face value to account for the time value of money and the inherent liability risk.
III. Regulatory Compliance and Documentation (KDOR Guidance)
The statutory provisions require the Transferee to provide documentation of the acquired credit “in the manner required by the secretary of revenue”.3 Adhering to the specific forms and filing procedures dictated by the KDOR is mandatory for the validation of the transfer and the subsequent claiming of the credit.
A. Notification and Registration of Transfer (Form K-260)
The formal registration of the credit transfer is accomplished through the completion and submission of Form K-260, the Tax Credit Transfer Notification Form.4 This form serves as the official mechanism for notifying the KDOR that a credit has been conveyed by agreement between the Transferor and the Transferee.7
The notification process requires joint action: both the Transferor (the owner selling the credit) and the Transferee (the party receiving the credit) must sign and complete the K-260.7 This form must detail key financial aspects of the transaction, specifically the dollar amount of credit being received by the Transferee and the dollar amount paid by the Transferee for the credit.7
The KDOR clarifies that Form K-260 is solely a notification document and “is NOT a transfer agreement between the transferor and transferee”.7 This distinction is critical for Transferees, who must ensure that a separate, legally binding commercial agreement is executed. This contract is necessary to define representations, warranties, and indemnification rights, particularly regarding the validity of the original Qualified Research Expenditures (QREs) calculated by the Transferor. Upon processing the K-260, the KDOR issues a formal Certificate of Credit Transfer. The Transferee is mandated to retain copies of both the signed K-260 and the Certificate of Credit Transfer with their tax records for evidentiary support during any subsequent audit.7
B. Claiming the Acquired Credit (Schedule K-53)
The utilization of the transferred credit is documented annually using Schedule K-53, the Kansas Research and Development Credit form.8 The claiming process is sequential, requiring specific calculations to be performed by the Transferor before the Transferee can finalize their return.
Prerequisite Transferor Filing
The Transferor must complete Part A of Schedule K-53, which is the Computation of Maximum Allowable Credit.9 This section establishes the foundational figures upon which the Transferee’s claim rests, including:
- Total Credit (Line 6): This represents the full, generated face value of the credit.9
- Maximum Credit Allowed in Any One Tax Year (Line 7): This is calculated as 25% of the Total Credit (Line 6) and establishes the annual utilization ceiling.9
The Transferor must provide a copy of this completed Part A to the Transferee. The reliance of the Transferee on the Transferor’s calculation for the total credit base (Line 6) underscores the necessity of robust due diligence, as any future KDOR adjustment to the Transferor’s QREs directly diminishes the value of the asset held by the Transferee.
Transferee Completion Requirements
The Transferee completes the remainder of the form, specifically Parts B, C, and E, and Part D if there are carryforwards from prior tax years.9
- Part B – Computation of Allowed Credit: The Transferee utilizes Line 9 in this section. If the credit has been transferred, the Transferee enters the dollar amount of credit received through the transfer here.9 This line determines the credit amount allowed for the current tax year’s expenditures (or transferred credit).
- Part C – Computation of Carry Forward Credit: Line 10 determines the unused portion of the credit by subtracting the amount claimed (Line 9) from the Total Credit (Line 6, provided by the Transferor). This establishes the ongoing balance of the credit base.9
- Part D – Computation of Credits From Prior Years: This section is used in subsequent years (Year 2+) to track the running balance of the original credit base that has been carried forward. It requires reference to prior K-53 schedules to calculate the available carryforward amount (Line 18).9
- Part E – Computation of Total Credit Claimed: Line 19 requires the Transferee to enter their total Kansas tax liability for the current year after all other previously claimed credits. The final amount claimed (Line 20) is determined by entering the lesser of (1) the sum of the credit claimed for the current year (Line 9) and any applicable carryforward (Line 18), OR (2) the Transferee’s actual tax liability (Line 19).9 This mechanism ensures the credit is used only to the extent of the tax due and remains strictly non-refundable.
C. Due Diligence and Inheritance of Risk
A significant aspect of the Transferee’s legal position is the concept of inherited risk. The credit claimed by the Transferee remains “subject to the limitations and requirements in place at the time the credit was earned” by the Transferor.4 Therefore, the Transferee assumes the risk that the underlying QREs calculated by the Transferor may be disallowed or adjusted by the KDOR during a subsequent audit, even years after the transfer occurred. This could result in a reduction or forfeiture of the asset purchased by the Transferee.
To mitigate this exposure, sophisticated transactional planning is essential. Since the 25% annual limitation (Line 7) is permanently tied to the original Total Credit (Line 6), any reduction to Line 6 by an auditor immediately reduces the Transferee’s ability to utilize the credit in the future. Consequently, the Transferee must secure strong contractual indemnification from the Transferor, ensuring that any financial loss resulting from a successful state challenge to the original QRE calculation is recoverable. Furthermore, the timing of the transfer is administratively important: the Transferee should link the final payment to the issuance of the Certificate of Credit Transfer from the KDOR, confirming official state recognition of the asset transfer and mitigating the risk of administrative denial after funds have been remitted.7
IV. Utilization Mechanics: Annual Limitations and Carryforward
The practical realization of the acquired R&D tax asset is managed entirely by the utilization mechanics defined in K.S.A. 79-32,182b(b). This structure ensures a measured and non-immediate benefit for the Transferee.
A. Application of the 25% Annual Limit
The primary restraint on the Transferee’s ability to monetize the asset is the annual limitation: “the amount of such credit allowable for deduction from the taxpayer’s tax liability shall not exceed 25% of the total amount of such credit plus any applicable carry forward amount”.3 This 25% constraint effectively mandates a minimum four-year period (100% divided by 25%) for the full utilization of the credit, assuming the Transferee maintains sufficient tax liability throughout that period.
The credit is further protected by an indefinite carryforward provision. The statute specifies that any amount of the credit that exceeds the Transferee’s tax liability in a given year “may be carried forward until the total amount of the credit is used”.3 This indefinite carryforward capability guarantees that the asset will not expire due to temporary periods of low profitability, providing a critical element of stability for the long-term financial planning of the Transferee.4
B. The Interaction Between Tax Liability and the 25% Cap
The Transferee’s annual claim is subject to a dual limitation: the maximum 25% statutory capacity and the actual Kansas income tax liability.
The 25% rule establishes the maximum potential offset for the year. However, if the Transferee’s actual tax liability (K-53 Line 19) is less than this 25% maximum, the claim is capped at the liability amount (K-53 Line 20).9 The resulting under-utilization means that the unclaimed portion of the credit is not wasted or lost, but simply remains in the total credit base to be carried forward to the following year, still subject to the 25% maximum constraint in the subsequent period. This dynamic confirms that the transferred R&D credit functions strictly as a defensive, non-refundable offset, rather than a refundable cash equivalent.
The legislative design, by imposing the 25% utilization constraint, essentially creates an artificial tax amortization schedule for the Transferee. This mechanism forces the realization of the tax benefit over multiple fiscal years, thereby mitigating the immediate budgetary impact on the state while spreading the economic stimulus over time.
C. Implications for Financial Planning
The structured deferral imposed by the 25% cap fundamentally dictates the financial valuation of the asset. Transferees performing due diligence must calculate the Net Present Value (NPV) of the tax savings stream, which will be significantly discounted due to the mandatory four-year minimum realization schedule and the inherent risk of tax liability volatility.
As a result, the ideal Transferee profile is a taxpayer—whether corporate or otherwise—that projects consistently high Kansas taxable income over an extended horizon (four to ten years). Entities with volatile or uncertain future tax liabilities face greater risk, as any period of low profitability prolongs the utilization timeline and further erodes the NPV of the credit. The commitment to acquiring a large, capped credit necessitates that the Transferee maintains strong, profitable operations within Kansas to accelerate the use of the purchased tax asset, creating a secondary economic incentive for the Transferee to invest and remain profitable in the state.
V. Practical Case Study and Financial Modeling of Transferee Utilization
A practical example demonstrates how the Transferee applies the annual utilization limitations to the acquired R&D credit base.
A. Scenario Setup
Assume Beta Manufacturing Corp., a profitable Kansas corporate filer (K-120), acquires a newly generated Kansas R&D tax credit from a startup (Transferor) that had no current tax liability.
- Total Credit Transferred: $1,000,000 (Generated in TY 2024).
- Maximum Annual Claim: $250,000 (25% of $1,000,000, K-53 Line 7).
- Transferee Filing Form: Schedule K-53 submitted with Form K-120.
B. Numerical Example: Multi-Year Utilization Adherence
The following table models the utilization of the $1,000,000 credit over a five-year period, illustrating the impact of the 25% cap and fluctuating tax liabilities.
Transferee R&D Credit Utilization Projection (Beta Manufacturing Corp.)
| Tax Year | Max Allowable Claim (25% Cap) | Transferee Tax Liability (Before Credit) | Credit Claimed (K-53 Line 20) | Remaining Carryforward (Unused Base) |
| 2024 (Acquisition) | $250,000 | $600,000 | $250,000 | $750,000 |
| 2025 | $250,000 | $200,000 | $200,000 | $550,000 |
| 2026 | $250,000 | $300,000 | $250,000 | $300,000 |
| 2027 | $250,000 | $400,000 | $250,000 | $50,000 |
| 2028 | $250,000 | $150,000 | $50,000 | $0 |
| Total Utilized: | $1,000,000 |
C. Detailed Step-by-Step Analysis
Tax Year 2024 (Initial Claim): The Transferee’s liability ($600,000) far exceeds the statutory capacity ($250,000). The Transferee claims the maximum allowed, $250,000. The carryforward base is reduced to $750,000.
Tax Year 2025 (Under-utilization Due to Liability): The maximum capacity remains $250,000 (25% of the original base). However, the Transferee’s actual tax liability is only $200,000. Because the credit is non-refundable, the claim is limited by the liability to $200,000 (K-53 Line 20). The remaining $50,000 of the 25% capacity is effectively left unused that year. The unused base is reduced by the claimed amount ($750,000 – $200,000), leaving a carryforward of $550,000. This scenario highlights the inherent tax liability risk assumed by the Transferee.
Tax Year 2028 (Exhaustion of Asset): The Transferee’s remaining carryforward base is only $50,000. Although the 25% maximum capacity is still technically $250,000, and the liability is $150,000, the claim is ultimately limited to the remaining value of the asset, $50,000. The credit base is fully utilized, and the carryforward balance becomes zero.
The analysis confirms that the Transferee manages a dual risk: the credit risk (potential audit invalidation of the base credit) and the tax liability risk (insufficient future taxable income to fully use the annual 25% capacity). The indefinite carryforward ensures that any under-utilization due to low liability is not forfeited, but simply deferred, extending the monetization timeline.
VI. Conclusion: Strategic Implications for the Transferee
The Kansas R&D tax credit transfer provisions, enacted for tax years 2023 and beyond, have positioned the Transferee as a crucial financial partner for R&D-performing entities. Acquisition of this credit constitutes a complex financial investment requiring strategic compliance and risk management.
For successful utilization, the Transferee must integrate legal, tax, and financial controls. This includes mandatory compliance with KDOR requirements, specifically the timely filing of Form K-260, signed by both parties, and the subsequent receipt and retention of the Certificate of Credit Transfer.7 The annual utilization process requires meticulous adherence to Schedule K-53, accurately incorporating the Transferor’s initial calculation of the Total Credit (Line 6) and the derived 25% annual ceiling (Line 7).9
The fundamental strategic consideration for the Transferee lies in managing the financial deferral created by the 25% annual utilization cap.3 The acquisition price must be calculated based on the discounted NPV of this realized stream of tax offsets, requiring Transferees to project stable, long-term Kansas tax liabilities to ensure optimal and timely monetization. Furthermore, because the Transferee inherits the original requirements and limitations of the credit 4, robust legal agreements providing indemnification against future audit adjustments to the credit base are indispensable components of the transactional due diligence.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










